Translate this page into:
Complications of chemoport in children with cancer: Experience of 54,100 catheter days from a tertiary cancer center of Southern India
*Corresponding author: Dr. S. Aparna. aparnasmurthy25@gmail.com
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
Abstract
Abstract
Background: Chemoport is an essential part of the management of children with cancer and provides long-term venous access. There are few studies from resource poor countries reporting complications of chemoport. Aims: This study was aimed at describing the complications of chemoport in patients with cancer. Materials and Methods: This retrospective observational study analyzed 200 patients <15 years of age who underwent chemoport insertion. The medical records of these patients were reviewed for the patient characteristics, diagnosis, nature of port use, port-related complications and their management. Results: A total of 209 ports were implanted in 200 patients and 24 ports were removed due to port-related complications. There were 122 boys and 78 girls whose ages ranged from 4 months to 13 years (median age 2.5 years). About72% of patients were <2 years old. The cumulative duration of catheterization was 54,100 days. Of 209 ports, there were 36 complications that led to the removal of 21 ports. Port-related infection was the most common infection observed in our study (0.66/1000 catheter days and 11.9%). Mechanical complications were seen in 9 patients. Venous thrombosis and skin necrosis occurred in one patient each. Conclusions: Use of chemoport is safe and is a boon for children with cancer in developing countries with incidence of complications similar to Western countries. Although use of chemoport is associated with complications, they are easily managed. With stringent catheter care by trained personnel, some complications can be prevented.
Keywords
References
- Adler A, Yaniv I, Steinberg R, Solter E, Samra Z, Stein J, et al. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients. J Hosp Infect 2006;62:358-65.
- De Backer A, Vanhulle A, Otten J, Deconinck P. Totally implantable central venous access devices in pediatric oncology – Our experience in 46 patients. Eur J Pediatr Surg 1993;3:101-6.
- Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 1982;92:706-12.
- Blanchette VS, al-Musa A, Stain AM, Filler RM, Ingram J. Central venous access catheters in children with haemophilia. Blood Coagul Fibrinolysis 1996;7 Suppl 1:S39-44.
- Abdul-Rauf A, Gauderer M, Chiarucci K, Berman B. Long-term central venous access in patients with sickle cell disease. Incidence of thrombotic and infectious complications. J Pediatr Hematol Oncol 1995;17:342-5.
- Deerojanawong J, Sawyer SM, Fink AM, Stokes KB, Robertson CF. Totally implantable venous access devices in children with cystic fibrosis: Incidence and type of complications. Thorax 1998;53:285-9.
- Al-Bassam A, Al-Rabeeah A, Fouda K, Al-Ashwal A, Ozand PT. Implantable central venous access devices in children with metabolic disease. Metabolism 1998;47:900-2.
- Wildhaber B, Kistler W, Caflisch U. Experiences with the Port-A-Cath system in children. Schweiz Med Wochenschr 2000;130:732-8.
- Hengartner H, Berger C, Nadal D, Niggli FK, Grotzer MA. Port-A-Cath infections in children with cancer. Eur J Cancer 2004;40:2452-8.
- Tobiansky R, Lui K, Dalton DM, Shaw P, Martin H, Isaacs D. Complications of central venous access devices in children with and without cancer. J Paediatr Child Health 1997;33:509-14.
- Biffi R, Orsi F, Pozzi S, Pace U, Bonomo G, Monfardini L, et al. Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: A randomized trial. Ann Oncol 2009;20:935-40.
- Ignatov A, Hoffman O, Smith B, Fahlke J, Peters B, Bischoff J, et al. An 11-year retrospective study of totally implanted central venous access ports: Complications and patient satisfaction. Eur J Surg Oncol 2009;35:241-6.
- Rosenthal VD. Central line-associated bloodstream infections in limited-resource countries: A review of the literature. Clin Infect Dis 2009;49:1899-907.
- Dillon PA, Foglia RP. Complications associated with an implantable vascular access device. J Pediatr Surg 2006;41:1582-7.